SMS Lifesciences India Limited (SMSLIFE.NS)

INR 1133.7

(1.45%)

Revenue Summary of SMS Lifesciences India Limited

SMS Lifesciences India Limited's latest annual revenue in 2023 was 3.05 Billion INR , down -3.04% from previous year.
SMS Lifesciences India Limited's latest quarterly revenue in 2024 Q1 was 925.48 Million INR , up 2.84% from previous quarter.
SMS Lifesciences India Limited reported a annual revenue of 3.15 Billion INR in annual revenue 2022, down -9.14% from previous year.
SMS Lifesciences India Limited reported a annual revenue of 3.47 Billion INR in annual revenue 2021, up 34.9% from previous year.
SMS Lifesciences India Limited reported a quarterly revenue of 720.53 Million INR for 2023 Q3, up 4.03% from previous quarter.
SMS Lifesciences India Limited reported a quarterly revenue of 692.61 Million INR for 2023 Q2, down -7.22% from previous quarter.

Annual Revenue Chart of SMS Lifesciences India Limited (2023 - 2015)

Historical Annual Revenue of SMS Lifesciences India Limited (2023 - 2015)

Year	Revenue	Revenue Growth
2023	3.05 Billion INR	-3.04%
2022	3.15 Billion INR	-9.14%
2021	3.47 Billion INR	34.9%
2020	2.57 Billion INR	0.32%
2019	2.56 Billion INR	-31.24%
2018	3.73 Billion INR	78.7%
2017	2.08 Billion INR	-3.27%
2016	2.15 Billion INR	0.0%
2015	- INR	0.0%

Year	Revenue	Revenue Growth
2024 Q1	925.48 Million INR	2.84%
2023 Q3	720.53 Million INR	4.03%
2023 Q2	692.61 Million INR	-7.22%
2023 Q1	746.51 Million INR	17.13%
2023 Q4	899.91 Million INR	24.9%
2023 FY	3.05 Billion INR	-3.04%
2022 Q2	812.59 Million INR	-1.23%
2022 FY	3.15 Billion INR	-9.14%
2022 Q4	637.31 Million INR	-27.82%
2022 Q1	822.75 Million INR	-11.74%
2022 Q3	882.93 Million INR	8.66%
2021 Q4	932.21 Million INR	2.37%
2021 Q3	910.59 Million INR	4.97%
2021 Q1	762.7 Million INR	2.54%
2021 FY	3.47 Billion INR	34.9%
2021 Q2	867.51 Million INR	13.74%
2020 Q1	547.49 Million INR	30.88%
2020 FY	2.57 Billion INR	0.32%
2020 Q4	743.79 Million INR	11.73%
2020 Q3	665.69 Million INR	7.79%
2020 Q2	617.59 Million INR	12.81%
2019 Q2	763.66 Million INR	-17.63%
2019 FY	2.56 Billion INR	-31.24%
2019 Q4	418.3 Million INR	-10.22%
2019 Q3	465.92 Million INR	-38.99%
2019 Q1	927.15 Million INR	-27.36%
2018 Q3	965 Million INR	8.18%
2018 FY	3.73 Billion INR	78.7%
2018 Q4	1.27 Billion INR	32.27%
2018 Q1	598.78 Million INR	10.62%
2018 Q2	892.02 Million INR	48.97%
2017 FY	2.08 Billion INR	-3.27%
2017 Q4	541.28 Million INR	-18.58%
2017 Q1	458.31 Million INR	-18.16%
2017 Q2	510.43 Million INR	11.37%
2017 Q3	664.77 Million INR	30.24%
2016 Q1	583.37 Million INR	0.0%
2016 Q2	491.02 Million INR	-15.83%
2016 FY	2.15 Billion INR	0.0%
2016 Q3	610.94 Million INR	24.42%
2016 Q4	560.02 Million INR	-8.33%
2015 FY	- INR	0.0%

Peer Revenue Comparison of SMS Lifesciences India Limited

Name	Revenue	Revenue Difference
Biocon Limited	147.55 Billion INR	97.927%
Blue Jet Healthcare Limited	7.11 Billion INR	57.004%
Concord Biotech Limited	9.98 Billion INR	69.345%
Dishman Carbogen Amcis Limited	26.15 Billion INR	88.303%
Jubilant Ingrevia Limited	41 Billion INR	92.538%
Lyka Labs Limited	1.05 Billion INR	-191.022%
Panacea Biotec Limited	5.59 Billion INR	45.283%
Piramal Pharma Limited	81.71 Billion INR	96.256%
Supriya Lifescience Limited	5.7 Billion INR	46.358%
Syngene International Limited	34.88 Billion INR	91.23%
TAKE Solutions Limited	656.08 Million INR	-366.343%
Zota Health Care Limited	1.8 Billion INR	-69.517%